Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor

NeuroMolecular Medicine

Volumn 9, Issue 2, 2007, Pages 195-204

  Martínez, Carmen ^a   García Martín, Elena ^a   Alonso Navarro, Hortensia ^b   Jiménez Jiménez, Félix Javier ^b   Benito León, Julián ^c   García Ferrer, Isabel ^b   Vázquez Torres, Pilar ^b   Puertas, Inmaculada ^b   Zurdo, José M ^c   López Alburquerque, Tomás ^d   Agúndez, José A G ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL DE MÓSTOLES   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

CYP2C19; CYP2C8; CYP2C9; Essential tremor; Genetics; Polymorphism

Indexed keywords

CYTOCHROME P450 2C; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 10Q; CLINICAL FEATURE; CONTROLLED STUDY; DNA ISOLATION; ESSENTIAL TREMOR; FEMALE; GENE AMPLIFICATION; GENE DISRUPTION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PENETRANCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX RATIO;

EID: 34447579174     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02685892     Document Type: Article

References (47)

1. Abbruzzese G., Pigullo S., Di Maria E., et al. (2001) Clinical and genetic study of essential tremor in the Italian population. Neurol. Sci. 22, 39-40.
2. Agundez J. A., Jimenez-Jimenez F. J., Tejeda R., et al. (1997a) CYP2D6 polymorphism is not associated with essential tremor. Eur. Neurol. 38, 99-104.
3. Agundez J. A., Rodriguez I., Olivera M., et al. (1997b) CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians. Age Ageing. 26, 147-151.
4. Ahmadi K. R., Weale M. E., Xue Z. Y., et al. (2005) A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat. Genet. 37, 84-89.
5. Alonso-Navarro H., Martinez C., Garcia-Martin E., et al. (2006) CYP2C19 Polymorphism and Risk for Essential Tremor. Eur. Neurol. 56, 119-123.
6. Altshuler D., Brooks L. D., Chakravarti A., Collins F. S., Daly M. J., and Donnelly P. (2005) A haplotype map of the human genome. Nature 437, 1299-1320.
7. Bathum L., Andersen-Ranberg K., Boldsen J., Brosen K., and Jeune B. (1998) Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity. Role of CYP2D6 and CYP2C19 in longevity. Eur. J. Clin. Pharmacol. 54, 427-430.
8. Benito-Leon J., Bermejo-Pareja F., Morales J. M., Vega S., and Molina J. A. (2003) Prevalence of essential tremor in three elderly populations of central Spain. Mov. Disord. 18, 389-394.
9. Delaforge M., Pruvost A., Perrin L., and Andre F. (2005) Cytochrome P450-mediated oxidation of glucuronide derivatives: example of estradiol-17 beta-glucuronide oxidation to 2-hydroxyestradiol-17beta-glucuronide by CYP 2C8. Drug Metab. Dispos. 33, 466-473.
10. Eaton D. L. (2000) Biotransformation enzyme polymorphism and pesticide susceptibility. Neurotoxicology 21, 101-111.
11. Garcia-Martin E., Martinez C., Ladero J. M., and Agundez J. A. (2006) Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. Mol. Diagn. Ther. 10, 29-40.
12. Garcia-Martin E., Martinez C., Tabares B., Frias J., and Agundez J. A. (2004) Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms. Clin. Pharmacol. Ther. 76, 119-127.
13. Gulcher J. R., Jonsson P., Kong A., (1997) Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat. Genet. 17, 84-87.
14. Hazai E. and Kupfer D. (2005) Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze methoxychlor demethylation in human liver microsomes. Drug Metab. Dispos. 33, 157-164.
15. Higgins J. J., Loveless J. M., Jankovic J., and Patel P. I. (1998) Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov. Disord. 13, 972-977.
16. Higgins J. J., Lombardi R. Q., Pucilowska J., Jankovic J., Tan E. K., and Rooney J. P. (2005) A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 64, 417-421.
17. Higgins J. J., Jankovic J., Lombardi R. Q., et al. (2003) Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics 4, 185-189.
18. Houlston R. S. and Peto J. (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene 23, 6471-6476.
19. Illarioshkin S. N., Rakhmonov R. A., Ivanova-Smolenskaia I. A., et al. (2002) [Molecular genetic analysis of essential tremor]. Genetika 38,1704-1709.
20. Jankovic J., Beach J., Schwartz K., and Contant C. (1995) Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology 45, 645-648.
21. Jimenez-Jimenez F. J., de Toledo Heras M., Alonso-Navarro H., et al. (2005) Environmental risk-factors for essential tremor. Parkinson Relat. Disord. 11, 207.
22. Jimenez-Jimenez F. J., Tabernero C., Mena M. A., et al. (1991) Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine. J. Neurochem. 57, 81-87.
23. Kim J. H., Cho Y. H., Kim J. K., Park Y. G., and Chang J. W. (2005) Frequent sequence variation at the ETM2 locus and its association with sporadic essential tremor in Korea. Mov. Disord. 20, 1650-1653.
24. Klose T. S., Blaisdell J. A., and Goldstein J. A. (1999) Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J. Biochem. Mol. Toxicol. 13, 289-295.
25. Knupfer H., Knupfer M. M., Hotfilder M., and Preiss R. (1999) P450-expression in brain tumors. Oncol. Res. 11, 523-528.
26. Koller W. C. and Busenbark K. L. (1997) Essential tremor. In: Watts R. L., Koller W. C., eds. Movement Disorders. New York, McGraw-Hill, 365?385.
27. Kotnis A., Sarin R., and Mulherkar R. (2005) Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility. J. Biosci. 30, 93-102.
28. Kubota T., Hibi N., and Chiba K. (1998) Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population. Biochem. Pharmacol. 55, 2039-2042.
29. Louis E. D. (2001) Etiology of essential tremor: should we be searching for environmental causes? Mov. Disord. 16, 822-829.
30. Louis E. D. (2005) Essential tremor. Lancet Neurol. 4, 100-110.
31. Louis E. D., Ottman R., and Hauser W. A. (1998) How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov. Disord. 13, 5-10.
32. Louis E. D., Zheng W., Jurewicz E. C., et al. (2002) Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 59, 1940-1944.
33. Martinez C., Garcia-Martin E., Blanco G., Gamito F. J., Ladero J. M., and Agundez J. A. (2005) The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects. Br. J. Clin. Pharmacol. 59, 62-69.
34. McFayden M. C., Melvin W. T., and Murray G. I. (1998) Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem. Pharmacol. 55, 825-830.
35. Narimatsu S., Yonemoto R., Saito K., et al. (2006) Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochem. Pharmacol. 71, 1377-1385.
36. O'Suilleabhain P. and Dewey R. B. Jr. (2002) Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov. Disord. 17, 382-386.
37. Pigullo S., Di Maria E., Marchese R., et al. (2003) Essential tremor is not associated with alpha-synuclein gene haplotypes. Mov. Disord. 18, 823-826.
38. Rebbeck T. R. (2003) Epidemiological approaches to the identification of cancer predisposition genes. Methods Mol. Biol. 222, 309-325.
39. Salemi G., Aridon P., Calagna G., Monte M., and Savettieri G. (1998) Population-based case-control study of essential tremor. Ital. J. Neurol. Sci. 19, 301-305.
40. Sazci A., Ergul E., and Bayulkem K. (2004) Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey. Mov. Disord. 19,1472-1476.
41. Schulz-Jander D. A. and Casida J. E. (2002) Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reduction. Toxicol. Lett. 132, 65-70.
42. Shatunov A., Sambuughin N., Jankovic J., et al. (2006) Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain 129, 2318-2331.
43. Tachibana S., Fujimaki Y., Yokoyama H., Okazaki O., and Sudo K. (2005) In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2- methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4 -imidazolylmethyl)-1H- indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. Drug Metab. Dispos. 33, 1628-1636.
44. Tan E. K., Matsuura T., Nagamitsu S., Khajavi M., Jankovic J., and Ashizawa T. (2000) Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology 54,1195-1198.
45. Usmani K. A., Karoly E. D., Hodgson E., and Rose R. L. (2004) In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavincontaining monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos. 32, 333-339.
46. Walton R., Kimber M., Rockett K., Trafford C., Kwiatkowski D., and Sirugo G. (2005) Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10. Nat. Genet. 37, 915-916; author reply 916.
47. Yasar U., Lundgren S., Eliasson E., et al. (2002) Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. Biochem. Biophys. Res. Commun. 299, 25-28.